Barclays PLC Codex Dna, Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	N/A	-1,790 Reduced 78.68%	485 $1,000
Q3 2022 Nov 03, 2022	SELL	$1.7 - $2.36 $17,384 - $24,133	-10,226 Reduced 81.8%	2,275 $4,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $6.45 $12,661 - $45,369	-7,034 Reduced 36.01%	12,501 $23,000
Q1 2022 May 16, 2022	BUY	$4.12 - $10.36 $80,484 - $202,382	19,535 New	19,535 $105,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.